Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
NATCO Pharma today announced that the United States Patent and Trademark Office (the PTO) issued a final office action rejecting Teva's application seeking a reissue of U.S. Patent No. 5,800,808 (808 Patent), which was found to be invalid by the court of appeals for the Federal Circuit in July 2013.
NATCO Pharma announced that the US Supreme Court agreed to hear appeal in a patent fight on Copaxone.
Natco Pharma... More..